论文信息 - Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies? - 字舞流文

Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?

A. Blaschek | H. Kölbel | D. Gläser | U. Schara-Schmidt | W. Müller-Felber | K. Vill | C. Köhler | I. Hannibal | K. Eggermann | O. Schwartz